RU96109024A - METHOD FOR PREVENTION OF THROMBOTIC COMPLICATIONS OF ATHEROSCLEROSIS - Google Patents

METHOD FOR PREVENTION OF THROMBOTIC COMPLICATIONS OF ATHEROSCLEROSIS

Info

Publication number
RU96109024A
RU96109024A RU96109024/14A RU96109024A RU96109024A RU 96109024 A RU96109024 A RU 96109024A RU 96109024/14 A RU96109024/14 A RU 96109024/14A RU 96109024 A RU96109024 A RU 96109024A RU 96109024 A RU96109024 A RU 96109024A
Authority
RU
Russia
Prior art keywords
atherosclerosis
prevention
blood
thrombotic complications
fibrinogen
Prior art date
Application number
RU96109024/14A
Other languages
Russian (ru)
Other versions
RU2141843C1 (en
Inventor
В.М. Крейнес
С.В. Власов
А.И. Кравченко
В.Б. Еремеев
А.И. Мартынов
Original Assignee
Государственный научно-клинический центр охраны здоровья шахтеров
Filing date
Publication date
Application filed by Государственный научно-клинический центр охраны здоровья шахтеров filed Critical Государственный научно-клинический центр охраны здоровья шахтеров
Priority to RU96109024A priority Critical patent/RU2141843C1/en
Priority claimed from RU96109024A external-priority patent/RU2141843C1/en
Publication of RU96109024A publication Critical patent/RU96109024A/en
Application granted granted Critical
Publication of RU2141843C1 publication Critical patent/RU2141843C1/en

Links

Claims (2)

1. Способ профилактики тромботических осложнений атеросклероза, включающий его медикаментозное лечение с последующей криоплазмасорбцией, отличающийся тем, что определяют количество фибриногена в крови и при его значении более 4,5 г/л, появлении в крови продуктов деградации фибриногена, повышение активности факторов свертывания и вязкости крови предварительно перед назначением лекарственных средств осуществляют реинфузию термически модифицированной плазмы ежедневно в течении 3-х дней.1. A method for the prevention of thrombotic complications of atherosclerosis, including its medical treatment with subsequent cryoplasmasorption, characterized in that the amount of fibrinogen in the blood is determined and when it is more than 4.5 g / l, the appearance of fibrinogen degradation products in the blood, the increase in the activity of coagulation factors and viscosity blood prior to the appointment of drugs carry out reinfusion of thermally modified plasma daily for 3 days. 2. Способ по п.1, отличающийся тем, что термическую модификацию осуществляют при температуре 56oC.2. The method according to claim 1, characterized in that the thermal modification is carried out at a temperature of 56 o C.
RU96109024A 1996-05-05 1996-05-05 Method of preventing thrombotic complications of atherosclerosis RU2141843C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU96109024A RU2141843C1 (en) 1996-05-05 1996-05-05 Method of preventing thrombotic complications of atherosclerosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU96109024A RU2141843C1 (en) 1996-05-05 1996-05-05 Method of preventing thrombotic complications of atherosclerosis

Publications (2)

Publication Number Publication Date
RU96109024A true RU96109024A (en) 1998-08-10
RU2141843C1 RU2141843C1 (en) 1999-11-27

Family

ID=20180238

Family Applications (1)

Application Number Title Priority Date Filing Date
RU96109024A RU2141843C1 (en) 1996-05-05 1996-05-05 Method of preventing thrombotic complications of atherosclerosis

Country Status (1)

Country Link
RU (1) RU2141843C1 (en)

Similar Documents

Publication Publication Date Title
DK0913156T3 (en) Use of activated protein C for the treatment of hypercoagulation conditions associated with sepsis
NO963568D0 (en) Pharmaceutical composition for the treatment of blood coagulation disorders, methods for the preparation thereof and its use
CA2081703A1 (en) Thrombin and method of producing the same
DE69313212D1 (en) Method and device for producing blood component products
NO974874L (en) Systems and methods for direct controlled preparation of blood products such as platelets harvested for therapeutic purposes
DE69534130D1 (en) COMPOUNDS FOR THE TREATMENT OF DISEASES ASSOCIATED WITH VASCULOGENESIS AND / OR ANGIOGENESIS.
NZ333695A (en) Method for treating gastrointestinal damage with hyperimmunised milk and hyperimmunised egg
AU3067995A (en) Method for treatment of sleep apnea
EP0888776A4 (en) A product of heat treatment of uronic acid, food, drink or drug including the product
DE69113386D1 (en) Manufacture of medications for the treatment of asthma using (S) -alpha-fluoromethyl-histidine and its esters.
CA2176258A1 (en) Device and method for photoactivation
ES2073425T3 (en) A NEW GLYCOPROTEIN OF THE THROMBOMODULIN TYPE SUSCEPTIBLE TO BE OBTAINED FROM THE URINE.
EP0229654A3 (en) Treatment of non-acne inflammatory and infectious dermatoses
AU5048090A (en) Human derived monocyte attracting purified protein product useful in a method of treating infection and neoplasm in human body, and the cloning of full length cdna thereof
NO305868B1 (en) Alginate Oligosaccharide, Process for Preparation of Alginate Oligosaccharide in Blood Pressure Enhancing Nutrient
NO170686C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 3-L-PYROGLUTAMYL-L-THIAZOLIDINE-4-CARBOXYLIC ACID
RU96109024A (en) METHOD FOR PREVENTION OF THROMBOTIC COMPLICATIONS OF ATHEROSCLEROSIS
ATE135223T1 (en) MEDICINAL PRODUCTS FOR THE TREATMENT OF HYPERLIPIDEMIA AND/OR ATHEROSCLEROSIS
BR0012661A (en) Treatment Methods and Drug Screening Methods
AU7670687A (en) Improvements in or relating to the treatment of occlusive vascular diseases
CA2138793A1 (en) Use of a hymenoptera venom for the manufacture of a medicament for treating dna virus infections
DE69014501D1 (en) Process for the treatment of titanium alloy and piece made therewith.
AU1039492A (en) Process for the preparation of racemic and optically active 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid and its precursors
RU96119673A (en) METHOD FOR TREATING PAIN SYNDROME
UA31867A (en) Method for treating acute gastric ulcer complicated with bleeding